LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 243 filers reported holding LIGAND PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 4.76 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $38 | -99.9% | 572 | 0.0% | 0.00% | – |
| Q3 2022 | $49,000 | +157.9% | 572 | +155.4% | 0.00% | – |
| Q2 2022 | $19,000 | -24.0% | 224 | 0.0% | 0.00% | – |
| Q1 2022 | $25,000 | -45.7% | 224 | -24.8% | 0.00% | – |
| Q4 2021 | $46,000 | +70.4% | 298 | +49.0% | 0.00% | – |
| Q3 2021 | $27,000 | -22.9% | 200 | -26.2% | 0.00% | – |
| Q2 2021 | $35,000 | -12.5% | 271 | 0.0% | 0.00% | – |
| Q1 2021 | $40,000 | +53.8% | 271 | 0.0% | 0.00% | – |
| Q4 2020 | $26,000 | +52.9% | 271 | +39.0% | 0.00% | – |
| Q3 2020 | $17,000 | +54.5% | 195 | +107.4% | 0.00% | – |
| Q2 2020 | $11,000 | +22.2% | 94 | -26.0% | 0.00% | – |
| Q1 2020 | $9,000 | +800.0% | 127 | +1170.0% | 0.00% | – |
| Q4 2019 | $1,000 | -96.3% | 10 | -95.3% | 0.00% | – |
| Q1 2019 | $27,000 | +285.7% | 213 | +294.4% | 0.00% | – |
| Q4 2018 | $7,000 | -53.3% | 54 | 0.0% | 0.00% | – |
| Q3 2018 | $15,000 | +36.4% | 54 | 0.0% | 0.00% | – |
| Q2 2018 | $11,000 | – | 54 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knott David M Jr | 115,000 | $7,682 | 2.90% |
| VILLERE ST DENIS J & CO LLC | 483,347 | $32,287 | 2.52% |
| Monarch Partners Asset Management LLC | 62,327 | $4,163,444 | 1.23% |
| Chicago Capital, LLC | 319,054 | $21,312,820 | 1.18% |
| RICE HALL JAMES & ASSOCIATES, LLC | 285,634 | $19,080,351 | 1.09% |
| Stephens Investment Management Group LLC | 454,416 | $30,713,977 | 0.56% |
| Smith, Graham & Co., Investment Advisors, LP | 65,372 | $4,366,850 | 0.53% |
| WOODSTOCK CORP | 55,014 | $3,674,935 | 0.49% |
| Court Place Advisors, LLC | 15,533 | $1,037,605 | 0.38% |
| ISTHMUS PARTNERS, LLC | 19,830 | $1,324,644 | 0.20% |